CN102836272B

CN102836272B - Medicinal composition for treating prostate hyperplasia

Info

Publication number: CN102836272B
Application number: CN201210331316.XA
Authority: CN
Inventors: 王仲举
Original assignee: Individual
Current assignee: Individual
Priority date: 2012-09-10
Filing date: 2012-09-10
Publication date: 2014-10-15
Anticipated expiration: 2032-09-10
Also published as: CN102836272A

Abstract

The invention relates to a medicinal composition for treating prostate hyperplasia. The medicinal composition is prepared from the following materials by weight: 8-20 parts of cornu cervi degelatinatum, 8-15 parts of semen sinapis albae, 10-25 parts of radix rehmanniae preparata, 15-20 parts of radix aconiti lateralis, 8-15 parts of radix astragali, 12-30 parts of radix cyathulae, 15-25 parts of semen vaccariae, 20-25 parts of semen cuscutae, 10-15 parts of fructus psoraleae and 8-15 parts of carnis ostreae by mixing, pulverizing to 100-120 mesh, adding honey, and making pill. The medicinal composition has the advantages of high curative effect, no side effects and curative rate up to 89.7%.

Description

A kind of medicine for the treatment of prostatic hyperplasia

Technical field

The present invention relates to a kind of medicine, concrete relate to a kind of Chinese medicine preparation for the treatment of prostatic hyperplasia, the invention still further relates to the preparation method of this medicine.

Background technology

Prostatic hyperplasia is elderly men common disease, its cause of disease is because prostatic increase gradually produces contention effect to urethra and bladder outlet, show as clinically frequent micturition, urgent micturition, inferior the increasing and trouble urinating of urine at night, and can cause the complication such as urinary system infection, vesical calculus and hematuria, the quality of life of elderly men is produced and had a strong impact on.

Treatment to this disease at present, except operative treatment, also have gonadotherapy, stent therapy, block therapy etc., but because carrying out operative treatment, gerontal patient's physical weakness easily causes physical weakness, lead to complications, large or the expensive or effect of other therapies side effect generally and easily repeatedly, patient is reluctant to accept more.

Summary of the invention

The object of this invention is to provide a kind of medicine for the treatment of prostatic hyperplasia, therapeutic effect is good, and has no side effect.

Medicine of the present invention is that the raw material of Chinese medicine medicine by following parts by weight prepares:

Cornu Cervi Degelatinatum 8-20 Semen Sinapis Albae 8-15 Radix Rehmanniae Preparata 10-25

Radix Aconiti Lateralis Preparata 15-20 Radix Astragali 8-15 Radix Cyathulae 12-30

Semen Vaccariae 15-25 Semen Cuscutae 20-25 Fructus Psoraleae 10-15

Concha Ostreae 8-15.

Further, medicine of the present invention is that raw material of Chinese medicine medicine by following parts by weight prepares;

Cornu Cervi Degelatinatum 10 Semen Sinapis Albae 10 Radix Rehmanniaes Preparata 12

Radix Aconiti Lateralis Preparata 15 Radix Astragali 10 Radix Cyathulaes 20

Semen Vaccariae 20 Semen Cuscutae 25 Fructus Psoraleaes 12

Concha Ostreae 10.

The preparation method of medicine of the present invention is as follows:

By the raw material of Chinese medicine medicine mix homogeneously of described parts by weight, be ground into 100-120 object fine powder and make medicine activity component.

The active component making is added to necessary adjuvant according to conventional formulation processing method, can be processed into corresponding peroral dosage form, as powder, tablet, capsule, honeyed pill etc., the preferred pill of the present invention, adds the Mel that can make active component be mixed into ball to make pill according to conventional method.

The traditional Chinese medical science thinks and gasifies old deficiency of kidney-QI unable, and phlegm-damp is cohesion, and the blood vessels stasis of blood is stagnant, and the hypertrophy of accumulating in the course of time causes primary disease, Cornu Cervi Degelatinatum warming the kidney to activate YANG in prescription of the present invention, astringing to arrest bleeding; Semen Sinapis Albae warming the lung eliminating phlegm promoting the circulation of QI, resolving mass and removing the obstruction of the collateral pain relieving; The Radix Rehmanniae Preparata yin nourishing of enriching blood, life essence-filling, marrow-benefitting; Radix Aconiti Lateralis Preparata recuperating depleted YANG and rescuing the patient from collapse, mends fire supporing yang, dispersing cold for relieving pain; Radix Astragali strongly invigorating primordial QI, always controls the refreshing medicine of skin infection; Radix Cyathulae strongly invigorating primordial QI, always controls the refreshing medicine of skin infection; Semen Vaccariae helps Radix Achyranthis Bidentatae blood circulation promoting and blood stasis dispelling, again can diuresis promoting; Semen Cuscutae the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, solid tire stopping leak; Fructus Psoraleae warming the kidney to activate YANG, improving inspiration by invigorating kidney-QI, antidiarrheal; Concha Ostreae tranquillization with heavy prescription, YANG hyperactivity suppressing nourishing YIN, hard masses softening and resolving, restrains astringent or styptic treatment for spontaneous sweatingly, and all medicines share, and mend greatly ternary, blood circulation promoting and blood stasis dispelling, soft junction eliminating stagnation, treating both the principal and secondary aspects of a disease, not diuresis and urinating from logical.

Use clinically the present invention to carry out safety and observation of curative effect to treatment prostatic hyperplasia:

1, patient's data

Patient is 126 examples altogether, more than 45 one full year of life of age, below 65 one full year of life.

2, diagnostic criteria:

The < < new Chinese medicine guideline of clinical investigations > > that observed patient promulgates with reference to Ministry of Public Health is diagnostic criteria:

Dysuria history: urinate and hesitate, waste time and energy, urine line is thin, unable, residual urine sense, nocturia frequency, very person has urinary incontinence;

Anus touch: prostate two lateral lobes expand, or intermediate sulcus disappears;

Ultrasound investigation: Transrectal Ultrasound tomography is ideal, the large portion of prostate even density, symmetry expands, weight > 20g;

Residual urine volume is measured: adopt B ultrasonic method or urethral catheterization all can;

Uroflometry: urine amount >=200ml is advisable, maximum urine flow < 15ml/s;

Urethrocystography: can find upwards the impression of bladder and rear urethra are pressed elongated, lateral projection is the fan-shaped image of half exhibition.

Urethrocystoscope checks: can find prostate two lateral lobes or the hypertrophy in middle period, and protruding in urethra or bladder.

3, Therapeutic Method

The medicine of the oral embodiment of the present invention 1 of patient, every day, each was once oral sooner or later, each 3 balls, treating the course for the treatment of is 2 months.

4, curative effect determinate standard

The < < new Chinese medicine guideline of clinical investigations > > curative effect determinate standard of promulgating with reference to Ministry of Public Health;

Effective: prostate volume is reduced into original 60%, Qmax >=18 ml/s;

Effective: prostate volume is reduced into original below 80%, and residual urine volume reduces more than 50%, maximum urine flow 12ml/s;

Invalid: prostate volume is without significant change.

5, therapeutic effect

In 126 routine patients, recovery from illness 69 examples, effective 32 examples, effective 12 examples, total effective rate reaches 89.7%, invalid 13 examples, inefficiency is 10.3%.

The specific embodiment

Embodiment 1

Get Cornu Cervi Degelatinatum 0.8kg, Semen Sinapis Albae 1 kg, Radix Rehmanniae Preparata 2.5 kg, Radix Aconiti Lateralis Preparata 1.5 kg, the Radix Astragali 1 kg, Radix Cyathulae 2 kg, Semen Vaccariae 1.5 kg, Semen Cuscutae 2.5 kg, Fructus Psoraleae 1 kg, Concha Ostreae 1 kg;

By the raw material of Chinese medicine medicine mix homogeneously of described parts by weight, be ground into 100-120 object fine powder and make medicine activity component, add the Mel that can make active component be mixed into ball to make pill according to conventional method.

Embodiment 2

Get Cornu Cervi Degelatinatum 0.5kg, Semen Sinapis Albae 0.4kg, Radix Rehmanniae Preparata 1.25kg, Radix Aconiti Lateralis Preparata 1 kg, Radix Astragali 0.4kg, Radix Cyathulae 1.5kg, Semen Vaccariae 1 kg, Semen Cuscutae 1.15kg, Fructus Psoraleae 0.5kg, Concha Ostreae 0.75kg;

Embodiment 3

Get Cornu Cervi Degelatinatum 1kg, Semen Sinapis Albae 0.65kg, Radix Rehmanniae Preparata 0.8kg, Radix Aconiti Lateralis Preparata 1 kg, Radix Astragali 0.4kg, Radix Cyathulae 1.5kg, Semen Vaccariae 1 kg, Semen Cuscutae 1.15kg, Fructus Psoraleae 0.5kg, Concha Ostreae 0.75kg;

Claims

1. treat a medicine for prostatic hyperplasia, it is characterized in that being prepared by the raw material of Chinese medicine medicine of following parts by weight:

Semen Vaccariae 15-25 Semen Cuscutae 20-25 Fructus Psoraleae 10-15

Concha Ostreae 8-15.

2. the medicine for the treatment of prostatic hyperplasia according to claim 1, it is characterized in that being prepared by the raw material of Chinese medicine medicine of following parts by weight:

Radix Aconiti Lateralis Preparata 15 Radix Astragali 10 Radix Cyathulaes 20

Semen Vaccariae 20 Semen Cuscutae 25 Fructus Psoraleaes 12

Concha Ostreae 10.

3. described in claim 1 or 2, control the medicine of prostatic hyperplasia, its preparation method is as follows: